Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04235491 · ClinicalTrials.gov registry record

Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED)

A clinical trial of Bradycardia, sponsored by Medtronic.

Active
Registry status
37,000
Enrollment target
1
Study location

NCT04235491 is a study of Bradycardia that is active but no longer recruiting, run by Medtronic. The registered enrollment target is 37,000 participants, above the 3,137-participant average among 29 other Bradycardia trials with a reported enrollment target (1079% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04235491, a study of Bradycardia, is active but no longer recruiting, sponsored by Medtronic.

ACTIVE NOT RECRUITING
Registry status
37,000 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of the study is to meet the CMS mandated Coverage with Evidence Development requirement in the National Coverage Determination for Leadless Pacemakers as they apply to Medtronic Micra devices. The study uses administrative claims data of the Medicare population implanted with Micra AV leadless pacemakers or dual-chamber transvenous pacemakers. Patients are enrolled through submission of claims or encounter data to CMS.

Conditions Studied

Study Locations (1)

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 37,000 participants
Start Date 2020-02-06
Est. Completion 2029-06

Sponsor

Medtronic

30 total trials

What the Registry Record Tells You About NCT04235491

The ClinicalTrials.gov registry entry for NCT04235491 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 37,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,137-participant average among 29 other Bradycardia trials with a reported enrollment target (1079% higher). The listed sponsor is Medtronic, which has 30 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bradycardia appearing as the primary indexed condition, and to 0 interventions.

NCT04235491 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT04235491 about?

NCT04235491 is a clinical study titled "Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED)". The primary purpose of the study is to meet the CMS mandated Coverage with Evidence Development requirement in the National Coverage Determination for Leadless Pacemakers as they apply to Medtronic Micra devices. The study uses administrative claims data of the Medicare population implanted with Mic...

What is the current status of trial NCT04235491?

This trial is currently active not recruiting. The enrollment target is 37,000 participants. The study started on 2020-02-06. Estimated completion is 2029-06.

What conditions does trial NCT04235491 study?

This clinical trial studies the following conditions: Bradycardia.

Who is sponsoring clinical trial NCT04235491?

This trial is sponsored by Medtronic, which has 30 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04235491 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bradycardia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.